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Abstract
Background: Use of psychotropic drugs is widespread in Europe, and is markedly more common
in France than elsewhere. Young adults often fare less well than adolescents on health indicators
(injury, homicide, and substance use). This population-based study assessed disparities in
psychotropic drug use among people aged 18–29 from different socio-occupational groups and
determined whether they were mediated by educational level, health status, income, health-related
behaviours, family support, personality traits, or disability.
Methods:  A total of 1,257 people aged 18–29, randomly selected in north-eastern France
completed a post-mailed questionnaire covering sex, date of birth, height, weight, educational level,
occupation, smoking habit, alcohol abuse, income, health-status, diseases, reported disabilities, self-
reported personality traits, family support, and frequent psychotropic medication for tiredness,
nervousness/anxiety or insomnia. The data were analyzed using the adjusted odds ratios (ORa)
computed with logistic models.
Results: Use of psychotropic drugs was common (33.2%). Compared with upper/intermediate
professionals, markedly high odds ratios adjusted for sex were found for manual workers (2.57,
95% CI 1.02–6.44), employees (2.58, 1.11–5.98), farmers/craftsmen/tradesmen (4.97, 1.13–21.8),
students (2.40, 1.06–5.40), and housewives (3.82, 1.39–10.5). Adjusting for all the confounders
considered reduced the estimates to a pronounced degree for manual workers (adjusted OR 1.49,
non-significant) but only slightly for the other socio-occupational groups. The odds ratio for
unemployed people did not reach statistical significance. The significant confounders were: sex,
not-good health status, musculoskeletal disorders and other diseases, being worried, nervous or
sad, and lack of family support (adjusted odds ratios between 1.60 and 2.50).
Conclusion:  There were marked disparities among young adults from different socio-
occupational groups. Sex, health status, musculoskeletal diseases, family support, and personality
traits were related to use of psychotropic drugs. These factors mediated the higher risk strongly
among manual workers and slightly among the other groups.
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Background
Psychotropic drugs are widely used in Europe and mark-
edly more common in France than elsewhere [1,2]. They
have been shown to influence many aspects of health
(including the growth and development of children, gen-
eral health status, cancer, and quality of life) and to have
major socio-economic consequences [3-5]. Frequent psy-
chotropic drug use has a strong long-term association
with injury [6-9].
Young adulthood is an important period of development
and adaptation to working life. It is the age at which
health indicators such as injury, homicide, and substance
use, reach a peak, with levels higher even than those
among adolescents [10]. Young people in employment
are also at markedly greater risk of occupational injury
than other age-groups [6]. Longitudinal data indicate that
health risk increases and access to health care decreases
from the teen and adult years for most US race/ethnic
groups, and that relative rankings on a diverse range of
health indicators vary by sex and race/ethnicity (as do pat-
terns of change) – leading to fluctuating patterns of dis-
parity over time [11]. In the last decade, young adults in
Switzerland have been reported to be at increased risk of
work-related injury, overweight or obesity, inter-personal
violence, and regular use of alcohol, cigarettes and canna-
bis [12]. Even so, the health issues of young adulthood
have received relatively little attention compared with
those of adolescence, despite similarities in critical issues
[10].
It is important to investigate the use of psychotropic med-
ication and its correlates among young adults. People
who begin working at an early age tend to work in less
good environments, be under greater pressure, and expe-
rience more cumulative job stress, leading to fatigue,
work-related stress reactions, psychological and physical
overload, job dissatisfaction, health problems, and physi-
cal and mental disabilities [13-17] and consequently to
psychotropic drug use [1,18-20]. In the European Union,
3.6% of the total burden of disease is directly related to
the work environment [21]. In France, one-third of the
working population use medications or other legal psy-
choactive substances in order to cope with work-related
difficulties [22]. Psychotropic medications are used by
many socio-occupational groups, but their administration
is particularly common among manual workers [22].
Some material and psychosocial factors (low educational
level, low income, smoking, alcohol abuse, lack of family
support, certain personality traits) have been shown to
influence health status, injury, disability, and mortality
among various populations [6,14,23,24]. It would be
interesting to investigate whether those factors, altered
heath status, diseases, and disabilities relate to psycho-
tropic drug use in young adulthood. In the literature, char-
acteristics such as age, sex, body weight, smoking, alcohol
use, physical symptoms and diseases, psychological fac-
tors, behaviour, personality, family support, and quality
of life have been correlated with psychotropic medication
[1,13,25-29] but no study has focused on young adults. It
should be noted that smoking and alcohol use contribute
to 9.0% and 8.4%, respectively, of the total burden of dis-
eases in the European Union [21].
A key question is whether there are disparities in psycho-
tropic drug use among young adults from different socio-
occupational groups and, if so, whether they are mediated
by the factors listed above. Inequalities in health due to
material and psychosocial factors are of current concern
throughout Europe [30-33]. In Italy, their reduction is
part of the 1999–2000 national plan. A strategy for health
that incorporates objective measures of equality has been
established in Sweden. The government of the United
Kingdom has reduced inequalities in health among chil-
dren, and between socio-economic groups in general [34].
In France, reduction of inequalities in health has been an
objective of a law related to public health policy.
There is considerable debate over the models used to
explain inequalities in health, particularly with regard to
whether they are mediated by social determinants system-
atically related to socio-economic status [32,33], with par-
ticular emphasis on material deprivation and
psychosocial mechanisms [31]. Information about ine-
qualities and patterns of risk for psychotropic medication
in this context may aid the design of preventive measures,
and help practitioners and other relevant professionals to
provide appropriate health care and to monitor the sub-
jects most at risk. To our knowledge, no such investiga-
tions have been conducted in young adults.
The present study assessed frequent use of psychotropic
drugs among young adults (aged 18–29 years) from vari-
ous socio-economic groups in northeast France, and
investigated whether discrepancies were mediated by low
educational level, not-good heath status, musculoskeletal
disorders and other diseases, low income, smoking, alco-
hol abuse, lack of family support, certain personality
traits, or disability.
Methods
The initial sample consisted of everyone aged 15 years or
more living in 8,000 randomly selected households in the
Lorraine region of north-eastern France (2.3 million
inhabitants). Only households with a telephone were eli-
gible.
Before the initial survey, a 3-month media campaign (tel-
evision, print, and radio) was conducted in order to raiseInternational Journal for Equity in Health 2008, 7:3 http://www.equityhealthj.com/content/7/1/3
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awareness. The investigation was approved by the Com-
mission Nationale d'Informatique et Libertés, and written
informed consent was obtained from respondents.
The study protocol included an application to participate,
which ascertained the number of people in the house-
hold, followed by three standardized self-administered
questionnaires mailed at 1-month intervals, each with a
covering letter and a pre-paid reply envelope. When the
number of eligible individuals in a household was
unknown, two questionnaires were sent initially, fol-
lowed by another one later. Adolescents were free to ask
their parents about any questions they did not under-
stand. Questions covered: sex, date of birth, height,
weight, educational level, occupation (coded according to
the classification of the Institut National de la Statistique
et des Etudes Economiques, Paris), smoking habit, excess
alcohol use, perceived income, perceived health-status,
various diseases diagnosed by a physician, reported disa-
bilities according to the WHO international classification
[35], self-reported personality characteristics, family sup-
port, and psychotropic drug use.
Underweight and overweight were defined as body mass
index lower than 18.5 kg/m2 and higher than 25 kg/m2
respectively [36].
Alcohol abuse was defined using the Deta questionnaire
(at least two positive responses to four items: (i) con-
sumption considered excessive by the subject; (ii) con-
sumption considered excessive by people around the
subject, (iii) subject wishes to reduce consumption, and
(iv) consumption on waking) [6,14,37]. With regard to
self-reported personality characteristics, subjects were
asked whether they considered themselves: worried,
sociable, calm, aggressive, solitary, organised, nervous, or
sad (Yes/No) [26,38,39]. Self-perceived health-status was
addressed in the question: 'According to you, your health
status is ...' (Good/Average/Poor/Bad). For perceived
income, subjects were asked whether they considered
themselves: comfortable or well off; earning just enough;
coping, but not easily; or getting into debt. Family support
was addressed in the question: 'Are you satisfied or dissat-
isfied with support from your family over the last two
months?' (Very satisfied/Rather satisfied/No opinion/
Rather dissatisfied/Very dissatisfied). Lack of family sup-
port was defined as 'Very dissatisfied' or 'Rather dissatis-
fied'.
The following categories of disabilities were considered:
(a) sensory disabilities, with two items – vision and hear-
ing; and (b) cognitive disabilities, with four items – con-
centration and attention; orientation; problem solving;
and memory. Subjects were asked to 'indicate the
response which corresponds to your ability in the follow-
ing activities during the last 8 days...' (Without difficulty/
With some difficulty/With several difficulties/Unable to
comment).
With regard to psychotropic drugs, subjects were asked
whether they usually frequently used medication (pre-
scribed and/or non-prescribed) for tiredness, nervous-
ness/anxiety, or insomnia (Yes/No) [7,8,26,38].
Nine occupational categories were considered: (1) upper
occupations (intellectual professionals, senior managerial
staff and administrators, medical doctors, independent
professionals, engineers); (2) intermediate occupations
(managerial staff, school teachers, skilled technicians,
medical workers and social workers); (3) manual occupa-
tions (skilled manual workers, farm workers, semi-skilled
manual workers, unskilled manual workers); (4) employ-
ees; (5) farmers (farm managers)/craftsmen/tradesmen
(independent shop or business owners); (6) other
employed people and those whose occupation is
unknown; (7) students; (8) housewives; and (9) unem-
ployed people [6,7,40]. Educational level was categorized
into 'Primary school only', 'Middle and high school' and
'University'.
Of the 8,000 households included in the sample, mailings
to 193 (2%) were lost (due to addressing error or death).
Of 7,807 households contacted, 3,460 (44.3%) partici-
pated (all eligible members of the family took part in 86%
of those). In total, 6,234 subjects filled in a questionnaire;
18 were of unknown sex or age, leaving 6,216 subjects
who were similar in age and sex distribution to the popu-
lation of Lorraine (Table 1). The subpopulation of interest
here comprised 1,257 young adults aged 18–29.
Table 1: Distribution according to sex and age of the sample 
studied and of the Lorraine general population [54] (%)
The sample studied The Lorraine 
general population
No. of subjects 6,216 1,848,579
Percentage of women 52.4 51.5
Age (yr)
15–19 5.4 9.6
20–24 8.0 9.8
25–29 9.7 9.7
30–34 10.4 9.6
35–39 10.5 9.6
40–44 7.9 9.3
45–49 8.5 5.9
50–54 6.0 6.6
55–59 6.3 6.8
60–64 7.2 6.6
65–69 7.5 5.7
70 or over 12.6 10.8
Only people aged 15 or more were considered.International Journal for Equity in Health 2008, 7:3 http://www.equityhealthj.com/content/7/1/3
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Statistical analyses
The outcome variable was psychotropic drug use (all types
combined). Independent variables were: socio-occupa-
tional category, educational level, underweight, over-
weight, being a current smoker, alcohol abuse, not-good
health status, musculoskeletal disorders and other dis-
eases, hearing disability, visual disability, cognitive disa-
bilities, being worried, not sociable, not calm, aggressive,
solitary, not organised, nervous, or sad, living situation,
lack of satisfaction with family support, and low perceived
income.
First, crude odds ratios (OR) and 95% confidence inter-
vals (CI) were used to assess the relationships between
various factors and psychotropic drug use. Then two
rounds of logistic regression analyses were carried out
with two sets of independent variables and covariates: the
first round included socio-occupational category and sex
only, and the second round included all the risk factors
studied which were related to psychotropic drug use with
p < 0.10. In these analyses the upper and intermediate
occupations were combined and used as the reference
group (both contained a small number of subjects and the
risk for psychotropic drug use was the same) (Table 2).
Table 2: Relationships between various risk factors and frequent psychotropic drug use in 1,257 young adults aged 18–29: crude 
relative risk and 95% CI
No. of subjects % Crude odds ratio 95% CI
Women (vs. men) 712 56.6 2.08*** 1.44–3.01
Socio-occupational category: vs. managers, intellectual professionals (73)
Intermediate professionals 58 4.6 0.94 0.20–4.38
Manual workers 150 11.9 2.20 0.71–6.81
Employees 262 20.8 2.93* 1.01–8.50
Farmers, craftsmen and tradesmen 17 1.4 3.70 0.74–18.4
Other occupations or unknown 92 7.3 1.87 0.55–6.34
Students 463 36.8 2.52§ 0.89–7.16
Housewives 53 4.2 5.05** 1.53–16.7
Unemployed people 89 7.1 1.94 0.57–6.58
Educational level: vs. university (413)
Middle and high school 750 60.0 0.93 0.65–1.35
Primary school 94 7.5 1.11 0.58–2.14
Underweight vs. 'normal' (873) 95 9.8 1.31 0.73–2.36
Overweight vs. 'normal' (873) 289 24.9 0.81 0.53–1.25
Current smoking 476 37.9 1.52* 1.08–2.13
Alcohol abuse 97 7.7 1.46 0.83–2.57
Not-good health status 264 21.0 3.54*** 2.49–5.05
Diagnosed diseases vs. disease- free (724)
Musculoskeletal disorders (MSD) 193 15.3 1.96** 1.22–3.15
Other diseases 198 15.8 1.82** 1.13–2.94
Both MSD and other diseases 142 11.3 3.90*** 2.47–6.17
Hearing disability 61 4.8 1.40 0.82–3.18
Visual disability 128 10.2 2.11** 1.33–3.35
Cognitive disability (at least one) 336 26.7 2.04*** 1.44–2.89
Self-reported personality traits
Worried 347 27.6 2.90*** 2.06–4.09
Not sociable 557 44.3 1.34§ 0.95–1.87
Not calm 880 70.0 1.99*** 1.30–3.03
Aggressive 116 9.2 1.68* 1.01–2.78
Solitary 165 13.0 0.69 0.39–1.20
Not organised 861 68.5 1.02 0.71–1.46
Nervous 441 35.1 3.11*** 2.20–4.39
Sad 56 4.5 5.24*** 2.98–9.23
Living situation: vs. living with family or in a couple (1012)
With friends 20 1.7 0.87 0.20–3.78
Alone 147 12.5 1.60§ 1.00–2.56
Lack of family support 116 9.2 2.29*** 1.42–3.67
Low perceived income 603 48.0 1.20 0.86–1.68
*p < 0.05, **p < 0.01, ***p < 0.001, § NS but p < 0.10.
Underweight: body mass index < 18.5 kg/m2, overweight: body mass index > 25 kg/m2, 'normal' weight: 18.5 kg/m2 ≤ body mass index < 25 kg/m2.
In parentheses: no. of subjects.International Journal for Equity in Health 2008, 7:3 http://www.equityhealthj.com/content/7/1/3
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Results
Frequent use of psychotropic drugs was common (12.2%
overall, 7.6% for nervousness or anxiety, 4.6% for fatigue,
and 2.6% for insomnia) and twice as high among women
than men (odds ratio adjusted for occupation 2.03, 95%
CI 1.38–3.01).
The characteristics of the subjects are shown in Table 2.
Factors significantly related to psychotropic drug use were:
sex, socio-occupational category, current smoking, not-
good health status, musculoskeletal disorders and other
diseases, visual disability, cognitive disabilities, being
worried, not calm, aggressive, nervous, or sad, and lack of
satisfaction with family support.
The findings of the two rounds of analyses are presented
in Table 3. Compared with upper/intermediate occupa-
tions, markedly high and significant odds ratios adjusted
for sex were found for manual workers (2.57), employees
(2.58), farmers/craftsmen/tradesmen (4.97), students
(2.40), and for housewives (3.82). Adjusting for all the
confounders considered reduced the estimates slightly,
and the odds ratios remained significant or close to signif-
icant, with the exception of manual workers (1.49, non-
significant). Significant confounders were: sex, not-good
health status, musculoskeletal disorders and other dis-
eases, being worried, nervous or sad, and lack of family
support.
Table 3: Relationships between various risk factors and frequent psychotropic drug use in 1,257 young adults aged 18–29: adjusted odds 
ratio and 95% CI computed with logistic model
Logistic regression model including socio-occupational category and sex only
Socio-occupational category: vs. managers, intellectual and intermediate professionals (131)
Manual workers 2.57* 1.02–6.44
Employees 2.58* 1.11–5.98
Farmers, craftsmen and tradesmen 4.97* 1.13–21.8
Other occupations or unknown 1.69 0.60–4.74
Students 2.40* 1.06–5.40
Housewives 3.82** 1.39–10.5
Unemployed people 1.74 0.62–4.89
Woman (vs. men) 2.03*** 1.38–3.01
Logistic regression model including all factors considered (Table 2) Socio-occupational category: vs. 
managers, intellectual and intermediate professionals (131)
Manual workers 1.49 0.56–4.03
Employees 2.22§ 0.92–5.36
Farmers, craftsmen and tradesmen 5.40* 1.14–25.4
Other occupations or unknown 1.49 0.51–4.39
Students 2.22§ 0.95–5.18
Housewives 3.23* 1.09–9.60
Unemployed people 1.50 0.51–4.44
Woman (vs. men) 1.60* 1.05–2.45
Current smokers 1.38§ 0.94–2.01
Not-good health status 2.01*** 1.34–3.02
Diagnosed diseases vs. disease free
Musculoskeletal disorders (MSD) 1.80* 1.08–3.02
Other diseases 1.32 0.78–2.23
Both MSD and other diseases 2.13** 1.25–3.62
Visual disability 1.44 0.85–2.46
Cognitive disability (at least one) 0.84 0.55–1.29
Self-reported personality traits
Worried 1.83** 0.23–2.73
Not sociable 1.27 0.87–1.86
Not calm 1.15 0.71–1.85
Aggressive 1.06 0.60–1.89
Nervous 1.95*** 1.29–2.95
Sad 2.50** 1.30–4.82
Living alone 1.65§ 0.97–2.80
Lack of family support 2.03** 1.19–3.45
*p < 0.05, **p < 0.01, ***p < 0.001, § NS but p < 0.10.
a Also adjusted for socio-occupational category.
The logistic model considered only those factors related to psychotropic drug use with p < 0.10 (Table 2).International Journal for Equity in Health 2008, 7:3 http://www.equityhealthj.com/content/7/1/3
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Discussion
The present study demonstrates marked differences
between socio-occupational groups in frequent use of psy-
chotropic drugs (for fatigue, nervousness, anxiety, or
insomnia) among young adults aged 18–29. Use was
strongly mediated among manual workers, and slightly
mediated among the other socio-occupational groups, by
not-good health status, musculoskeletal disorders/other
diseases, lack of family support, and certain personality
traits such as being worried, nervous or sad. Current
smoking, and visual and cognitive disabilities had signifi-
cant crude odds ratios but they became non-significant
when controlling for all factors considered. This could be
explained by the interdependence of factors.
This study reports that frequent psychotropic drug use was
common among young adults. Comparison with other
investigations is difficult because of variations in the pop-
ulations studied, the psychotropic drugs considered, and
the methodological approaches used. In addition, few
researchers have focused on young adults. In France,
9.3%, 16.1% and 5.9% of adults (aged 18–75) used anti-
depressants, sleeping pills, and drugs to improve their
physical/intellectual performance [15]. One-third of
French workers used drugs for work-related reasons, 20%
to feel better, 12% to control an awkward symptom, and
18% to relax after a difficult day's work [22]. The ESEMeD
study focused on the use of antidepressant, anxiolytic, and
antipsychotic or mood-stabilizing drugs in adults (aged
18+) [1]. It reported a prevalence of 19.2% in France,
15.5% in Spain, 13.7% in Italy, 13.2% in Belgium, 7.4%
in the Netherlands, and 5.9% in Germany. Bruffaerts et al.
[41] reported that about 19% of Belgian people aged over
18 use a psychotropic drug.
Our results confirm the well-known sex ratio [1,26,28].
Women and female adolescents are more likely than their
male counterparts to have any mental disorder and to take
psychotropic drugs [1,2,26], to be given such drugs fol-
lowing a medical consultation, to receive longer courses,
and to renew the treatment [42]. It should be noted that
we found a crude odds ratio of 2.08 and an adjusted odds
ratio of 1.60 when controlling for socio-occupational cat-
egory and other confounders, whereas the ESEMeD study
(conducted in six European countries) reported an
adjusted odds ratio of 2.1 (95% CI 1.9–2.4) when con-
trolling for age, marital status, educational level, employ-
ment, disability, illness leave, urban/rural location, and
country [1]. This suggests that the sex ratio was only partly
explained by these risk factors or confounders. Sex differ-
ence may in part be attributable to a higher incidence of
depressive symptoms among females, and their greater
willingness to seek medical help [2].
The present study reveals that housewives and students
are at high risk for psychotropic drug use, whereas unem-
ployed young adults are not. Overall, housewives had less
good health status than female workers did, although this
pattern was more consistent for women of low educa-
tional level [43]. University students report higher levels
of anxiety and depressive symptoms than are seen in gen-
eral population norms [44]. Several stressors, such as
financial problems, and academic pressures and their con-
sequences on social life, have an adverse effect on the
mental health of students [45].
An important finding of our study is that there are marked
disparities in psychotropic drug use among young adults
from different socio-occupational groups. Manual work-
ers, employees, farmers, craftsmen, and tradesmen were at
high risk compared with upper/intermediate profession-
als. This was expected as work conditions, diseases, occu-
pational injuries, impairments, disabilities, and health-
related behaviours also differ greatly [6,15,18,23,37,46]
and may increase psychotropic drug use [1,15,37]. Similar
differences were observed between socio-occupational
groups in impairments among subjects aged less than 40
years [14]. Health hazards at work are still a major deter-
minant of poor health [30]. In the European Union, 3.6%
of the total burden of disease is directly related to work
environments [30]. In France, the disparities between
social groups in morbidity, mortality and premature mor-
tality are higher than in the other western European coun-
tries [47]. Poor working conditions, and particularly
cumulative job stress, lead to physical and mental distur-
bances, and consequently to psychotropic drug use [18].
As noted above, one in every three French workers uses
medications or other legal psychoactive substances in
order to cope with work-related difficulties, and such use
is more common in employees and manual workers [22].
Fatigue is related to the physical demands of job[13]. The
volume of services provided and job dissatisfaction are
associated with hypnotic and tranquillizer use [19]. Work-
related fatigue is generated by repeated episodes of
adverse work experience and leads to the development of
stress reactions, psychological overload, and health prob-
lems [16]. Unemployed people here had a crude odds
ratio of 1.94, but it was not significant. However, that may
relate to a lack of statistical power, suggesting that a study
with a larger sample is needed.
As reported by other authors [10,11], we found that not-
good heath status and diseases were common in young
adults, and that they were strongly associated with psy-
chotropic drug intake. Musculoskeletal disorders were
most common and had a marked effect on psychotropic
medication. The high risk among subjects with not-good
health status or musculoskeletal disorders is of para-
mount importance as their prevalence is high in the pop-International Journal for Equity in Health 2008, 7:3 http://www.equityhealthj.com/content/7/1/3
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ulation of all ages [6,46]. Our results are consistent with
those of other studies that have shown that psychotropic
medication is associated with sick leave due to illness,
severe physical symptoms, and disability [1,48]. Not-
good health status, disease, and psychological distress are
strongly related to onset of fatigue and sleep problems
[25,49]. The presence of disease is, along with sensory or
cognitive disabilities, a long-term risk factor for injuries
and falls [6,23].
Our investigation shows that self-reported personality
traits were related to psychotropic drug use, and that the
simple items used were pertinent. Subjects who described
themselves as nervous, not calm, worried, aggressive or
sad were at increased risk. It may be that these self-
reported personality traits may be interpreted as a sort of
a justification for the use/abuse of psychotropic medica-
tions This finding was expected because self-reported per-
sonality traits are associated with smoking, alcohol
consumption, illicit drug use, and occupational injury
[38,39].
We found that lack of family support was strongly associ-
ated with psychotropic medication among young adults.
The role of the family in substance use is well docu-
mented, but not among this age group [29]. We also dem-
onstrated that visual and cognitive disabilities were
associated with psychotropic drug use in univariate anal-
ysis but not in multivariate analysis taking into account
sex, socio-occupational category, health status, disease,
family support, and personality traits. These results sug-
gest that the increased risks associated with visual and cog-
nitive disabilities could be attributed to those
confounders, indicating that preventive measures to
reduce psychotropic medication use among young adults
may need to be focused on health status, diseases, family
support, and personality traits rather than low education
level, disability, and low income which are mainly related
to socio-economic groups. The ESEMeD study found that
psychotropic drug use was related to lower levels of edu-
cation, but health status, disease, family support, and
socio-occupational category were not considered [1]. A
low education level is well known to be associated with
disability [23], membership of a lower social class, and
with adverse work conditions, lifestyle and living condi-
tions.
Our study failed to detect an association between frequent
psychotropic drug use and overweight, underweight, or
alcohol abuse. McElroy et al. [50] stated that obesity is
associated with depressive disorders, but most overweight
and obese people in the community do not have mood
disorders. Bültmann et al. [25] also found an increased
risk of fatigue in underweight women. Eating alone, social
isolation, and stressors are the main reasons for low
weight reported by the subjects concerned, mainly due to
poor nutritional status [51]. The present study found a sig-
nificant relationship between smoking and psychotropic
drug use in univariate analysis and a relationship close to
significance in multivariate analysis taking into account
all covariables. Smoking is associated with low socio-eco-
nomic group, low educational level, low income, living
alone, occupational and domestic injuries, and premature
death (≤ 70 yr) [8,40,52]. Preventive measures to reduce
psychotropic medication may consequently need to be
focused on smokers. Alcohol abuse affected 7.7% of
young adults; it had a crude odds ratio of 1.46 (slightly
lower than that for smoking (1.52)) that was non-signifi-
cant, again perhaps because of a lack of statistical power,
suggesting that a study with a larger sample is needed.
Our study demonstrates that disparities in frequent use of
psychotropic drugs were mediated by not-good health sta-
tus, musculoskeletal disorders, lack of family support, and
certain personality traits, all of which are generally
chronic or long-lasting conditions, particularly among
lower socio-economic groups. Therefore, psychotropic
drug use generated by them would also last for a long
time. Consequently, general practitioners may need to
monitor those of their patients most at risk. According to
the ESEMeD study, a significant proportion of individu-
als, both with and without mental disorders, are inappro-
priately treated [1]. These results confirm the roles of
material conditions and psychological factors in social
inequalities in health [15,17,30,31,37,53] but they also
point out a relatively important role of personality in psy-
chotropic medication. These findings may help us under-
stand socio-occupational inequalities in health, which, it
should be noted, are currently an area of considerable
interest and a preoccupation among policy officials in
most European countries and elsewhere [17,30,31].
Any selection bias here would be small: 96% of house-
holds had telephones at the time of the study, and only
16% had confidential addresses. Discussions before the
survey, for example with associations of people with disa-
bility, suggested that neither is likely to be related to
health status or living conditions. The age and sex distri-
butions of the sample reflect those of the general popula-
tion of Lorraine [54]. The percentage of manual workers
(18%) was similar to that of the Lorraine population
(21%) [54]. Note also that the incidence rate of occupa-
tional injury and the prevalence of various types of dis-
eases and disabilities, for example, are similar to those of
the general population [6,8,14,55]. The quality of the
completed questionnaires was very good. All the factors
studied had been validated and used in other investiga-
tions [6,15,26,37-39].International Journal for Equity in Health 2008, 7:3 http://www.equityhealthj.com/content/7/1/3
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The present study had some limitations. First, the psycho-
tropic drugs considered included those for fatigue, nerv-
ousness, anxiety, and/or insomnia. Fatigue is associated
with psychological distress and absence due to sickness
[16,56], and sleep problems are related to depression,
pain, and hypnotic-sedative use [48]. Second, the partici-
pation rate was modest although it was similar to that
achieved in similar surveys in France [1,57]. Third, as the
study used a self-administered questionnaire, the results
should be interpreted with caution, particularly given a
possible selection bias. However, the self-administered
occupational health history questionnaire is reliable and
valid [58]. The non-response bias in mailed health surveys
is small [59]. In population-based studies, self-assessment
of vision is similar between participants and non-partici-
pants [60], and self-assessment of memory is generally
valid [61].
Conclusion
The frequent use of psychotropic drugs was common and
there were marked disparities between young adults from
different socio-occupational groups. It was related to sex,
health status, musculoskeletal disorders, lack of family
support, and certain personality traits. These factors
strongly mediated the higher risk among manual workers
and slightly mediated it among the other socio-occupa-
tional groups. Preventive measures to reduce psychotropic
medication and inequalities in health should include
interventions to improve work conditions, health status,
and family environment, and to prevent musculoskeletal
disorders. General practitioners may help young adults
concerned to be more aware of the risks, to seek appropri-
ate health care, and to take remedial measures.
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